May 2024

  Adelaide, Australia - 7th May 2024  GPN Vaccines Ltd is pleased to announce the successful award of $936,000 in Round 3 of Brandon BioCatalyst’s CUREator Program. This funding marks an important milestone in the Company's journey toward advancing its novel pneumococcal vaccine, Gamma-PN. Funding from the CUREator...

Protecting children and adults from the world’s foremost bacterial pathogen